CLOSE X
GO

Nippon India Pharma Fund(G)

very highequitypharma & health care
513.52 4.31(0.85%) NAV as on 10 Mar 2026
1.75 % 1 M
10.36 % 1 Y
24.29 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.81

As on 28 Feb, 2026
age-icon Age :

21 yrs 9 m

Since 05 06 ,2004
exit_load Exit Load :

1%

aum AUM :

8,306.35 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.56

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2026
Others 0.30 %
Equity 99.70 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.08 %
Lupin Ltd.7.99 %
Divi's Laboratories Ltd.6.56 %
Dr. Reddy's Laboratories Ltd.5.81 %
Cipla Ltd.5.67 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs74.41
Hospital & Healthcare Services20.63
Retailing3.70
Business Support0.96
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 09-Mar-2026)290.14270.59428.87481.27509.22
Net Assets(Rs Crores) (as on 09-Mar-2026) 4931.89 4304.46 7125.28 8080.97 8306.35
Scheme Returns(%)(Absolute)14.83-6.8558.2410.947.42
B'mark Returns(%)(Absolute)NANANANANA
Category Rank43/7565/7617/9030/10242/118

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity513.524.31(0.85%)NAV As on 10 Mar, 202605-Jun-2004Inception Date8,306.35AUM In Cr.10.36%1Y24.29%3Y15.51%5Y19.83%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity38.460.67(1.77%)NAV As on 10 Mar, 202613-Jul-2018Inception Date6,801.16AUM In Cr.10.33%1Y28.11%3Y17.02%5Y19.22%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity31.350.34(1.10%)NAV As on 10 Mar, 202610-Jul-2019Inception Date854.04AUM In Cr.11.72%1Y24.64%3Y14.36%5Y18.68%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors